Hans Wigzell - Dec 12, 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Hans Wigzell
Stock symbol
SRPT
Transactions as of
Dec 12, 2024
Transactions value $
-$1,166,865
Form type
4
Date filed
12/16/2024, 08:00 PM
Previous filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise $144K +10.5K +45.97% $13.71 33.3K Dec 12, 2024 Direct
transaction SRPT Common Stock Sale -$1.31M -10.5K -31.49% $124.84 22.8K Dec 12, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Options (right to buy) Options Exercise $0 -10.5K -100% $0.00 0 Dec 12, 2024 Common Stock 10.5K $13.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.92 to $124.80, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.